0001225208-20-003799.txt : 20200228
0001225208-20-003799.hdr.sgml : 20200228
20200228192231
ACCESSION NUMBER: 0001225208-20-003799
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200226
FILED AS OF DATE: 20200228
DATE AS OF CHANGE: 20200228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hwang Angela
CENTRAL INDEX KEY: 0001725474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03619
FILM NUMBER: 20673595
MAIL ADDRESS:
STREET 1: 235 EAST 42ND STREET
STREET 2: ATTN: CORPORATE SECRETARY
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 135315170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2125732323
MAIL ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
4
1
doc4.xml
X0306
4
2020-02-26
0000078003
PFIZER INC
PFE
0001725474
Hwang Angela
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK
NY
10017
1
Group President
Common Stock
2020-02-26
4
M
0
14493.0000
34.5900
A
32470.0000
D
Common Stock
2020-02-26
4
F
0
1166.0000
34.7200
D
31304.0000
D
Common Stock
2020-02-26
4
F
0
11063.0000
36.8000
D
20241.0000
D
Common Stock
13338.0000
I
By Rule 16b-3 Plan
Common Stock
8532.0000
I
By Spouse
Phantom Stock Units
2020-02-26
4
A
0
3164.0000
0.0000
A
Common Stock
3164.0000
3164.0000
D
Stock Appreciation Rights
34.5900
2020-02-26
4
M
0
14493.0000
0.0000
D
2020-02-26
2020-02-26
Common Stock
14493.0000
0.0000
D
Stock Appreciation Rights
34.1000
2020-02-27
4
A
0
170368.0000
0.0000
A
2025-02-27
2025-02-27
Common Stock
170368.0000
170368.0000
D
Stock Appreciation Rights
34.1000
2020-02-27
4
A
0
145969.0000
0.0000
A
2027-02-27
2027-02-27
Common Stock
145969.0000
145969.0000
D
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
The reporting person disclaims beneficial ownership of the shares held by spouse.
Each unit represents one phantom share of common stock.
The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon) which have been deferred into the Pfizer Inc. Deferred Compensation Plan.
The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.
Susan E. Grant, by power of atty., for Angela Hwang
2020-02-28